[Treatment of seronegative myasthenia garvis]
[Article in
Japanese]
Affiliations
- PMID: 18210824
Item in Clipboard
[Treatment of seronegative myasthenia garvis]
[Article in
Japanese]
Rinsho Shinkeigaku.
2007 Nov.
Abstract
Myasthenia gravis (MG) is an antibody-mediated autoimmune disease of the neuromuscular junction. It is classified into 1) the nicotinic acetylcholine receptor antibodies (80-85%), 2) muscle- specific tyrosine kinase antibodies (5-10%), and 3) the above-mentioned antibody absent, double seronegative MG. In this symposium, I focused the treatment of double seronegative MG.
Similar articles
-
[Pathogenic antibodies in myasthenia gravis].Brain Nerve. 2010 Apr;62(4):411-8. Brain Nerve. 2010. PMID: 20420182 Review. Japanese.
-
[Therapeutic strategy in myasthenia gravis].Rev Neurol (Paris). 2009 Feb;165(2):149-54. doi: 10.1016/j.neurol.2009.01.005. Rev Neurol (Paris). 2009. PMID: 19233080 Review. French.
-
MuSK antibody-positive, seronegative myasthenia gravis in Korea.J Clin Neurosci. 2006 Apr;13(3):353-5. doi: 10.1016/j.jocn.2005.04.028. Epub 2006 Mar 20. J Clin Neurosci. 2006. PMID: 16546389
-
Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.Neurology. 2007 Aug 21;69(8):803-4. doi: 10.1212/01.wnl.0000267694.45244.f4. Neurology. 2007. PMID: 17709714 No abstract available.
-
Autoimmune myasthenia gravis.Expert Rev Neurother. 2009 Mar;9(3):351-8. doi: 10.1586/14737175.9.3.351. Expert Rev Neurother. 2009. PMID: 19271944 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical